First Trust Advisors LP Has $68.88 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

First Trust Advisors LP reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 131,970 shares of the medical equipment provider's stock after selling 5,972 shares during the quarter. First Trust Advisors LP's holdings in Intuitive Surgical were worth $68,883,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. M.E. Allison & CO. Inc. acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $449,000. Seilern Investment Management Ltd acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $82,517,000. Sycomore Asset Management boosted its position in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after buying an additional 4,079 shares during the period. Exome Asset Management LLC boosted its position in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock worth $3,649,000 after buying an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. boosted its position in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after buying an additional 525 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded up $6.46 during trading on Friday, reaching $514.59. The company's stock had a trading volume of 2,015,889 shares, compared to its average volume of 1,617,024. The business's fifty day moving average price is $511.92 and its 200-day moving average price is $533.05. The firm has a market cap of $183.29 billion, a price-to-earnings ratio of 80.28, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a one year low of $367.39 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period in the previous year, the company posted $1.50 earnings per share. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Ratings Changes

Several analysts have recently commented on the company. Leerink Partners raised their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Citigroup lifted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research report on Friday, January 24th. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Robert W. Baird reduced their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday. Finally, Erste Group Bank cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $598.95.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of the business's stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 35,454 shares of company stock worth $18,564,027 over the last three months. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.